{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:42:22Z","timestamp":1789774942999,"version":"4.0.1"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"6 October University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03382-x","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T23:11:52Z","timestamp":1774307512000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Licofelone-Loaded Poly(d,l-Lactide-Co-Glycolide) Nanoparticles to Enhance Therapeutic Action: A Novel Approach for the Topical Management of Irritant Contact Dermatitis"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0149-6995","authenticated-orcid":false,"given":"Khaled E.","family":"Abuelella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3980-719X","authenticated-orcid":false,"given":"Shaimaa","family":"Mosallam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8372-4682","authenticated-orcid":false,"given":"Amira A.","family":"El-Gazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8934-4990","authenticated-orcid":false,"given":"Ahmed Hassen","family":"Elshafeey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3143-5894","authenticated-orcid":false,"given":"Sara M.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"3382_CR1","doi-asserted-by":"crossref","first-page":"123458","DOI":"10.1016\/j.ijbiomac.2023.123458","volume":"232","author":"KE Abuelella","year":"2023","unstructured":"Abuelella KE, Abd-Allah H, Soliman SM, Abdel-Mottaleb MMA. Skin targeting by chitosan\/hyaluronate hybrid nanoparticles for the management of irritant contact dermatitis: In vivo therapeutic efficiency in mouse-ear dermatitis model. Int J Biol Macromol. 2023;232:123458.","journal-title":"Int J Biol Macromol"},{"key":"3382_CR2","first-page":"713","volume":"57","author":"G Novak-Bili\u0107","year":"2018","unstructured":"Novak-Bili\u0107 G, Vu\u010di\u0107 M, Japund\u017ei\u0107 I, Me\u0161trovi\u0107-\u0160tefekov J, Stani\u0107-Duktaj S, Lugovi\u0107-Mihi\u0107 L. Irritant and allergic contact dermatitis\u2013skin lesion characteristics. Acta Clin Croat. 2018;57:713\u20139.","journal-title":"Acta Clin Croat"},{"key":"3382_CR3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s12016-021-08875-0","volume":"61","author":"Y Li","year":"2021","unstructured":"Li Y, Li L. Contact dermatitis: classifications and management. Clin Rev Allergy Immunol. 2021;61:245\u201381.","journal-title":"Clin Rev Allergy Immunol"},{"key":"3382_CR4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jddst.2017.07.006","volume":"41","author":"SN Shrotriya","year":"2017","unstructured":"Shrotriya SN, Vidhate BV, Shukla MS. Formulation and development of Silybin loaded solid lipid nanoparticle enriched gel for irritant contact dermatitis. J Drug Deliv Sci Technol. 2017;41:164\u201373.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3382_CR5","doi-asserted-by":"crossref","unstructured":"Fujisawa R, Sakurai R, Oshizaka T, Mori K, Saitoh A, Takeuchi I, et al. Development of PSL-Loaded PLGA Nanoparticles for the treatment of allergic contact dermatitis. Colloids and Interfaces. 2024;8(3):39.","DOI":"10.3390\/colloids8030039"},{"key":"3382_CR6","doi-asserted-by":"crossref","first-page":"1658349","DOI":"10.3389\/fphar.2025.1658349","volume":"16","author":"MA El Hassab","year":"2025","unstructured":"El Hassab MA, Ibrahim MH, Abdel Mageed SS, Mahmoud AMA, Othman Ahmed ZS, Mosallam S, et al. Correction: formulation of zein nanoparticles for augmenting the anti-inflammatory activity of dexketoprofen. Front Pharmacol. 2025;16:1658349.","journal-title":"Front Pharmacol"},{"key":"3382_CR7","first-page":"901","volume":"48","author":"KE Abuelella","year":"2025","unstructured":"Abuelella KE, Mosallem S, Soliman SM, Elshafeey AH. Licofelone as a dual COX\/5-LOX inhibitor: a comprehensive review of its physicochemical, pharmacological, and therapeutic profiles in osteoarthritis and neurodegenerative disorders. Bull Pharm Sci Assiut Univ. 2025;48:901\u201322.","journal-title":"Bull Pharm Sci Assiut Univ"},{"key":"3382_CR8","doi-asserted-by":"crossref","first-page":"106587","DOI":"10.1016\/j.prostaglandins.2021.106587","volume":"157","author":"SM Razavi","year":"2021","unstructured":"Razavi SM, Khayatan D, Arab ZN, Momtaz S, Zare K, Jafari RM, et al. Licofelone, a potent COX\/5-LOX inhibitor and a novel option for treatment of neurological disorders. Prostaglandins Other Lipid Mediat. 2021;157:106587.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"3382_CR9","doi-asserted-by":"crossref","first-page":"e70114","DOI":"10.1111\/cbdd.70114","volume":"105","author":"N Agrawal","year":"2025","unstructured":"Agrawal N. A comprehensive review on the advancements of dual COX\u20102\/5\u2010LOX inhibitors as anti\u2010inflammatory drugs. Chem Biol Drug Des. 2025;105:e70114.","journal-title":"Chem Biol Drug Des"},{"key":"3382_CR10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4103\/0975-1483.51884","volume":"1","author":"K Gaur","year":"2009","unstructured":"Gaur K, Kori ML, Tyagi LK, Singh V, Nema RK, Tripathi P, et al. Licofelone-Novel Analgesic and Anti-In\u00df ammatory Agent for Osteoarthritis: An Overview. J Young Pharm. 2009;1:67.","journal-title":"J Young Pharm"},{"key":"3382_CR11","first-page":"1","volume":"2","author":"T Pachpute","year":"2025","unstructured":"Pachpute T. Polymeric nanoparticles for drug delivery: design, applications, and future perspectives. J Drug Deliv Biother. 2025;2:1\u20136.","journal-title":"J Drug Deliv Biother"},{"key":"3382_CR12","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/polym17070833","volume":"17","author":"L Eltaib","year":"2025","unstructured":"Eltaib L. Polymeric nanoparticles in targeted drug delivery: unveiling the impact of polymer characterization and fabrication. Polymers. 2025;17:833.","journal-title":"Polymers"},{"key":"3382_CR13","first-page":"135","volume":"48","author":"KE Abuelella","year":"2025","unstructured":"Abuelella KE, Mosallam S, Soliman SM, Elshafeey AH. Polymer-based biomaterials for wound healing: advances in natural, synthetic and hybrid biodegradable polymers for scar reduction and skin regeneration. Bull Pharm Sci Assiut Univ. 2025;48:135\u201374.","journal-title":"Bull Pharm Sci Assiut Univ"},{"key":"3382_CR14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.52711\/2231-5691.2025.00025","volume":"15","author":"R Bachhav","year":"2025","unstructured":"Bachhav R, Bachhav P, Deore R, Sonawane G, Surana K, Mahajan S. Biodegradable polymers in drug delivery: a detailed review. Asian J Pharm Res. 2025;15:153\u20138.","journal-title":"Asian J Pharm Res"},{"key":"3382_CR15","doi-asserted-by":"crossref","first-page":"107061","DOI":"10.1016\/j.ejps.2025.107061","volume":"208","author":"R Albash","year":"2025","unstructured":"Albash R, Fahmy AM, Shamsel-Din HA, Ibrahim AB, Bogari HA, Malatani RT, et al. Intranasal propranolol hydrochloride-loaded PLGA-lipid hybrid nanoparticles for brain targeting: optimization and biodistribution study by radiobiological evaluation. Eur J Pharm Sci. 2025;208:107061.","journal-title":"Eur J Pharm Sci"},{"key":"3382_CR16","first-page":"923","volume":"48","author":"KE Abuelella","year":"2025","unstructured":"Abuelella KE, Gaid SN, Abd El-Moniem Amer A. Poly (lactic-co-glycolic acid) in wound repair: a multifunctional platform for targeted drug delivery and tissue regeneration. Bull Pharm Sci Assiut Univ. 2025;48:923\u201347.","journal-title":"Bull Pharm Sci Assiut Univ"},{"key":"3382_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40204-017-0063-0","volume":"6","author":"L Naves","year":"2017","unstructured":"Naves L, Dhand C, Almeida L, Rajamani L, Ramakrishna S, Soares G. Poly (lactic-co-glycolic) acid drug delivery systems through transdermal pathway: an overview. Prog Biomater. 2017;6:1\u201311.","journal-title":"Prog Biomater"},{"key":"3382_CR18","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1080\/03639045.2020.1769127","volume":"46","author":"B Kandilli","year":"2020","unstructured":"Kandilli B, Ugur Kaplan AB, Cetin M, Taspinar N, Ertugrul MS, Aydin IC, et al. Carbamazepine and levetiracetam-loaded PLGA nanoparticles prepared by nanoprecipitation method: in vitro and in vivo studies. Drug Dev Ind Pharm. 2020;46:1063\u201372.","journal-title":"Drug Dev Ind Pharm"},{"key":"3382_CR19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12247-025-10240-z","volume":"21","author":"KE Abuelella","year":"2026","unstructured":"Abuelella KE, Mosallam S, El-Gazar AA, Elshafeey AH, Soliman SM. Polycaprolactone nanoparticles boost licofelone transdermal delivery for osteoarthritis: in vitro characterization, ex vivo permeability, and in vivo efficacy. J Pharm Innov. 2026;21:77.","journal-title":"J Pharm Innov"},{"key":"3382_CR20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.colsurfa.2018.11.014","volume":"562","author":"X Li","year":"2019","unstructured":"Li X, Wei Y, Lv P, Wu Y, Ogino K, Ma G. Preparation of ropivacaine loaded PLGA microspheres as controlled-release system with narrow size distribution and high loading efficiency. Colloids Surf A Physicochem Eng Asp. 2019;562:237\u201346. https:\/\/doi.org\/10.1016\/j.colsurfa.2018.11.014.","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"3382_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2021.118238","volume":"268","author":"SA Fereig","year":"2021","unstructured":"Fereig SA, El-Zaafarany GM, Arafa MG, Abdel-Mottaleb MMA. Tacrolimus-loaded chitosan nanoparticles for enhanced skin deposition and management of plaque psoriasis. Carbohydr Polym. 2021;268: 118238. https:\/\/doi.org\/10.1016\/j.carbpol.2021.118238.","journal-title":"Carbohydr Polym"},{"key":"3382_CR22","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3390\/pharmaceutics13040435","volume":"13","author":"MA T\u0103nase","year":"2021","unstructured":"T\u0103nase MA, Raducan A, Oancea P, Di\u0163u LM, Stan M, Petcu C, et al. Mixed pluronic\u2014Cremophor polymeric micelles as nanocarriers for poorly soluble antibiotics\u2014the influence on the antibacterial activity. Pharmaceutics. 2021;13:435.","journal-title":"Pharmaceutics"},{"key":"3382_CR23","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.bjbas.2017.03.004","volume":"6","author":"M Elmowafy","year":"2017","unstructured":"Elmowafy M, Samy A, Abdelaziz AE, Shalaby K, Salama A, Raslan MA, et al. Polymeric nanoparticles based topical gel of poorly soluble drug: formulation, ex-vivo and in vivo evaluation. Beni-Suef Univ J Basic Appl Sci. 2017;6:184\u201391. https:\/\/doi.org\/10.1016\/j.bjbas.2017.03.004.","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"key":"3382_CR24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1208\/s12249-025-03205-5","volume":"26","author":"NM Sheta","year":"2025","unstructured":"Sheta NM, Shamma RN, Hussein RRS, Salem SAM, Abdelaty LN, Abd El Gawad MM, et al. Voriconazole loaded spanlastics: design, formulation, optimization, and randomized controlled clinical insights for vulvovaginal candidiasis therapy. AAPS PharmSciTech. 2025;26:219.","journal-title":"AAPS PharmSciTech"},{"key":"3382_CR25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/08982104.2013.788025","volume":"23","author":"M Basha","year":"2013","unstructured":"Basha M, Abd El-Alim SH, Shamma RN, Awad GEA. Design and optimization of surfactant-based nanovesicles for ocular delivery of Clotrimazole. J Liposome Res. 2013;23:203\u201310.","journal-title":"J Liposome Res"},{"key":"3382_CR26","doi-asserted-by":"publisher","unstructured":"Abuelella KE, Abd-allah H, Soliman SM, Abdel- MMA. Intra-articular treatment of o\ufb06eoarthritis using novel biocompatible etoricoxib chitosan-hyaluronate hybrid microparticles. J Microencapsul. 2025;0:1\u201315.  https:\/\/doi.org\/10.1080\/02652048.2025.2490033.","DOI":"10.1080\/02652048.2025.2490033"},{"key":"3382_CR27","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1208\/s12249-021-01924-z","volume":"22","author":"S Mosallam","year":"2021","unstructured":"Mosallam S, Sheta NM, Elshafeey AH, Abdelbary AA. Fabrication of highly deformable bilosomes for enhancing the topical delivery of terconazole: in vitro characterization, microbiological evaluation, and in vivo skin deposition study. AAPS PharmSciTech. 2021;22:74.","journal-title":"AAPS PharmSciTech"},{"key":"3382_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123024","volume":"640","author":"MA Abdelbari","year":"2023","unstructured":"Abdelbari MA, El-Gazar AA, Abdelbary AA, Elshafeey AH, Mosallam S. Brij\u00ae integrated bilosomes for improving the transdermal delivery of niflumic acid for effective treatment of osteoarthritis: in vitro characterization, ex vivo permeability assessment, and in vivo study. Int J Pharm. 2023;640: 123024. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123024.","journal-title":"Int J Pharm"},{"key":"3382_CR29","doi-asserted-by":"crossref","first-page":"422","DOI":"10.22159\/ajpcr.2019.v12i1.30150","volume":"12","author":"AM Al-nima","year":"2019","unstructured":"Al-nima AM, Al-kotaji M, Al-iraqi O, H Ali Z. Preparation and evaluation of ultrasound transmission gel. Asian J Pharm Clin Res. 2019;12:422.","journal-title":"Asian J Pharm Clin Res"},{"key":"3382_CR30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-0044-1787293","volume":"15","author":"S Priya","year":"2025","unstructured":"Priya S, Shridhar P, Shekhara K, Shenthar S, Kudva SK. Tolnaftate-loaded ethosomal gel for topical delivery: formulation and in vitro evaluation. J Heal Allied Sci NU. 2025;15:26\u201331.","journal-title":"J Heal Allied Sci NU"},{"key":"3382_CR31","first-page":"343","volume":"17","author":"LY Yusan","year":"2025","unstructured":"Yusan LY, Subagio H. Anti-bacterial activity of chitosan nanoparticles gel from crab shell waste (Portunus pelagicus) against Staphylococcus aureus and Escherichia coli bacteria. Int J Appl Pharm. 2025;17:343\u20137.","journal-title":"Int J Appl Pharm"},{"key":"3382_CR32","doi-asserted-by":"crossref","first-page":"125700","DOI":"10.1016\/j.ijpharm.2025.125700","volume":"678","author":"RM El-Dahmy","year":"2025","unstructured":"El-Dahmy RM, El-Nabarawi MA, Mostafa HG, Salama A, Sheta NM. Role of chitosan coated invasomes in enhancement of transdermal delivery of tenoxicam for management of osteoarthritis: in vitro characterization, statistical optimization, ex vivo, and in vivo assessments. Int J Pharm. 2025;678:125700.","journal-title":"Int J Pharm"},{"key":"3382_CR33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s12247-025-10216-z","volume":"21","author":"KM Abdel-Haleem","year":"2026","unstructured":"Abdel-Haleem KM, Shamma RN, Abd El Gawad MM, Sheta NM. Tailoring Voriconazole novasomes: formulation, characterization, statistical optimization, ex-vivo permeation, and microbiological revelations. J Pharm Innov. 2026;21:12.","journal-title":"J Pharm Innov"},{"key":"3382_CR34","doi-asserted-by":"crossref","unstructured":"Shahani K, Panyam J. Highly loaded, sustained-release microparticles of curcumin for chemoprevention. J Pharm Sci. 2011;100:2599\u20132609. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0022354915320402. Accessed 25 Feb 2026.","DOI":"10.1002\/jps.22475"},{"key":"3382_CR35","doi-asserted-by":"crossref","first-page":"105912","DOI":"10.1016\/j.jddst.2024.105912","volume":"98","author":"MA Abdelbari","year":"2024","unstructured":"Abdelbari MA, El-Gazar AA, Abdelbary AA, Elshafeey AH, Mosallam S. Investigating the potential of novasomes in improving the trans-tympanic delivery of niflumic acid for effective treatment of acute otitis media. J Drug Deliv Sci Technol. 2024;98:105912.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3382_CR36","doi-asserted-by":"publisher","unstructured":"Albu MG, Ferdes M, Kaya DA, Ghica MV, Titorencu I, Popa L, Albu L. Collagen wound dressings with anti-inflammatory activity.\u00a0Mol Cryst Liq Cryst. 2012;555:271\u2013279. https:\/\/doi.org\/10.1080\/15421406.2012.635556.","DOI":"10.1080\/15421406.2012.635556"},{"key":"3382_CR37","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1007\/s13346-024-01728-1","volume":"15","author":"E Tun\u00e7el","year":"2025","unstructured":"Tun\u00e7el E, Tort S, Han S, Y\u00fccel \u00c7, T\u0131rnaks\u0131z F. Development and optimization of hydrogel-forming microneedles fabricated with 3d-printed molds for enhanced dermal diclofenac sodium delivery: a comprehensive in vitro, ex vivo, and in vivo study. Drug Deliv Transl Res. 2025;15:2116\u201345.","journal-title":"Drug Deliv Transl Res"},{"key":"3382_CR38","doi-asserted-by":"publisher","unstructured":"Aldeeb RAE, Ibrahim SSA, Khalil IA, Ragab GM, El-Gazar AA, Taha AA, Hassan DH, Gomaa AA, Younis MK. Enhancing collagen-based nanoemulgel for effective topical delivery of aceclofenac and citronellol oil: formulation, optimization, in-vitro evaluation, and in-vivo osteoarthritis study with a focus on HMGB-1\/RAGE\/NF-\u03baB pathway, Klotho, and miR-499a.\u00a0Drug Deliv Transl Res. 2024;14:3250\u20133268. https:\/\/doi.org\/10.1007\/s13346-024-01548-3.","DOI":"10.1007\/s13346-024-01548-3"},{"key":"3382_CR39","doi-asserted-by":"crossref","first-page":"122525","DOI":"10.1016\/j.ijpharm.2022.122525","volume":"631","author":"SM Soliman","year":"2023","unstructured":"Soliman SM, Teaima MH, Rashwan KO, Ali BM, Jasti BR, El-Nabarawi MA, et al. The deleterious effect of xylene-induced ear edema in rats: protective role of dexketoprofen trometamol transdermal invasomes via inhibiting the oxidative stress\/NF-\u03baB\/COX-2 pathway. Int J Pharm. 2023;631:122525.","journal-title":"Int J Pharm"},{"key":"3382_CR40","doi-asserted-by":"crossref","first-page":"5617234","DOI":"10.1155\/2018\/5617234","volume":"2018","author":"N Yasmen","year":"2018","unstructured":"Yasmen N, Aziz MA, Tajmim A, Akter MI, Hazra AK, Rahman SMM. Analgesic and anti\u2010inflammatory activities of diethyl ether and n\u2010hexane extract of Polyalthia suberosa leaves. Evid Based Complement Alternat Med. 2018;2018:5617234.","journal-title":"Evid Based Complement Alternat Med"},{"key":"3382_CR41","unstructured":"Bancroft JD, Gamble M. Theory and practice of histological techniques. 6th ed. Philadelphia: Churchill Livingstone Elsevier; 2008."},{"key":"3382_CR42","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ijpharm.2015.03.033","volume":"485","author":"AM Al-Mahallawi","year":"2015","unstructured":"Al-Mahallawi AM, Abdelbary AA, Aburahma MH. Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam. Int J Pharm. 2015;485:329\u201340. https:\/\/doi.org\/10.1016\/j.ijpharm.2015.03.033.","journal-title":"Int J Pharm"},{"key":"3382_CR43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/10717544.2020.1858997","volume":"28","author":"AM Fahmy","year":"2021","unstructured":"Fahmy AM, Hassan M, El-Setouhy DA, Tayel SA, Al-Mahallawi AM. Statistical optimization of hyaluronic acid enriched ultradeformable elastosomes for ocular delivery of voriconazole via Box-Behnken design: in vitro characterization and in vivo evaluation. Drug Deliv. 2021;28:77\u201386.","journal-title":"Drug Deliv"},{"key":"3382_CR44","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.3109\/03639045.2012.662510","volume":"39","author":"S Gupta","year":"2013","unstructured":"Gupta S, Agarwal A, Gupta NK, Saraogi G, Agrawal H, Agrawal GP. Galactose decorated PLGA nanoparticles for hepatic delivery of acyclovir. Drug Dev Ind Pharm. 2013;39:1866\u201373.","journal-title":"Drug Dev Ind Pharm"},{"key":"3382_CR45","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/jphp.12430","volume":"67","author":"NP Mistry","year":"2015","unstructured":"Mistry NP, Desai JL, Thakkar HP. Formulation and evaluation of tacrolimus-loaded galactosylated poly (lactic-co-glycolic acid) nanoparticles for liver targeting. J Pharm Pharmacol. 2015;67:1337\u201348.","journal-title":"J Pharm Pharmacol"},{"key":"3382_CR46","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.ajps.2015.09.004","volume":"11","author":"N Sharma","year":"2016","unstructured":"Sharma N, Madan P, Lin S. Effect of process and formulation variables on the preparation of parenteral paclitaxel-loaded biodegradable polymeric nanoparticles: a co-surfactant study. Asian J Pharm Sci. 2016;11:404\u201316. https:\/\/doi.org\/10.1016\/j.ajps.2015.09.004.","journal-title":"Asian J Pharm Sci"},{"key":"3382_CR47","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijpharm.2007.03.009","volume":"340","author":"J Liu","year":"2007","unstructured":"Liu J, Gong T, Wang C, Zhong Z, Zhang Z. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization. Int J Pharm. 2007;340:153\u201362.","journal-title":"Int J Pharm"},{"key":"3382_CR48","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3390\/pharmaceutics12070607","volume":"12","author":"B Tang","year":"2020","unstructured":"Tang B, Qian Y, Fang G. Development of lipid\u2013polymer hybrid nanoparticles for improving oral absorption of enoxaparin. Pharmaceutics. 2020;12:607.","journal-title":"Pharmaceutics"},{"key":"3382_CR49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.actbio.2020.04.028","volume":"110","author":"P Zarrintaj","year":"2020","unstructured":"Zarrintaj P, Ramsey JD, Samadi A, Atoufi Z, Yazdi MK, Ganjali MR, et al. Poloxamer: a versatile tri-block copolymer for biomedical applications. Acta Biomater. 2020;110:37\u201367.","journal-title":"Acta Biomater"},{"key":"3382_CR50","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3390\/pharmaceutics11120671","volume":"11","author":"E Russo","year":"2019","unstructured":"Russo E, Villa C. Poloxamer hydrogels for biomedical applications. Pharmaceutics. 2019;11:671.","journal-title":"Pharmaceutics"},{"key":"3382_CR51","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1208\/s12249-017-0710-8","volume":"18","author":"HA Salama","year":"2017","unstructured":"Salama HA, Ghorab M, Mahmoud AA, Abdel Hady M. PLGA nanoparticles as subconjunctival injection for management of glaucoma. AAPS PharmSciTech. 2017;18:2517\u201328.","journal-title":"AAPS PharmSciTech"},{"key":"3382_CR52","doi-asserted-by":"publisher","unstructured":"Matloub AA, AbouSamra MM, Salama AH, Rizk MZ, Aly HF, Fouad GI. Cubic liquid crystalline nanoparticles containing a polysaccharide from Ulva fasciata with potent antihyperlipidaemic activity. Saudi Pharm J. 2018;224\u201331. https:\/\/doi.org\/10.1016\/j.jsps.2017.12.007.","DOI":"10.1016\/j.jsps.2017.12.007"},{"key":"3382_CR53","doi-asserted-by":"crossref","first-page":"8753","DOI":"10.1021\/acs.langmuir.4c05309","volume":"41","author":"AD Miranda-Olvera","year":"2025","unstructured":"Miranda-Olvera AD, Dom\u00ednguez-Esquivel J-M, Martinez J. Hydrophilic\u2013lipophilic balance (HLB) correlation method for the selection of ionic liquid surfactant modifiers of the viscosity and emulsion stability of heavy oils. Langmuir. 2025;41:8753\u201365.","journal-title":"Langmuir"},{"key":"3382_CR54","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.micron.2006.08.003","volume":"38","author":"SB Rizwan","year":"2007","unstructured":"Rizwan SB, Dong Y-D, Boyd BJ, Rades T, Hook S. Characterisation of bicontinuous cubic liquid crystalline systems of phytantriol and water using cryo field emission scanning electron microscopy (cryo FESEM). Micron. 2007;38:478\u201385.","journal-title":"Micron"},{"key":"3382_CR55","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ijpharm.2007.08.034","volume":"350","author":"X Song","year":"2008","unstructured":"Song X, Zhao Y, Wu W, Bi Y, Cai Z. Pharmaceutical nanotechnology PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride\u202f: Systematic study of particle size and drug entrapment efficiency. Int J Pharm. 2008;350:320\u20139.","journal-title":"Int J Pharm"},{"key":"3382_CR56","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/156010","author":"D Sharma","year":"2014","unstructured":"Sharma D, Maheshwari D, Philip G, Rana R, Bhatia S, Singh M, et al. Formulation and optimization of polymeric nanoparticles for intranasal delivery of lorazepam using Box-Behnken design: in vitro and in vivo evaluation. Biomed Res Int. 2014. https:\/\/doi.org\/10.1155\/2014\/156010.","journal-title":"Biomed Res Int"},{"key":"3382_CR57","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ejpb.2005.02.006","volume":"60","author":"RH Mu","year":"2005","unstructured":"Mu RH. Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles ( SLN ). Eur J Pharm Biopharm. 2005;60:361\u201372.","journal-title":"Eur J Pharm Biopharm"},{"key":"3382_CR58","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ijpharm.2015.03.001","volume":"485","author":"S Laserra","year":"2015","unstructured":"Laserra S, Basit A, Sozio P, Marinelli L, Fornasari E, Cacciatore I, et al. Solid lipid nanoparticles loaded with lipoyl-memantine codrug: preparation and characterization. Int J Pharm. 2015;485:183\u201391. https:\/\/doi.org\/10.1016\/j.ijpharm.2015.03.001.","journal-title":"Int J Pharm"},{"key":"3382_CR59","doi-asserted-by":"crossref","first-page":"84","DOI":"10.21608\/ajps.2013.7097","volume":"48","author":"H Dawaba","year":"2013","unstructured":"Dawaba H. Application of 23 full-factorial design for development and optimization of biocompatible, biodegradable solid lipid nanoparticles containing curcumin. Al-Azhar J Pharm Sci. 2013;48:84\u2013101.","journal-title":"Al-Azhar J Pharm Sci"},{"key":"3382_CR60","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11696-020-01289-w","volume":"75","author":"P Shrimal","year":"2021","unstructured":"Shrimal P, Jadeja G, Patel S. Microfluidics nanoprecipitation of telmisartan nanoparticles: effect of process and formulation parameters. Chem Pap. 2021;75:205\u201314.","journal-title":"Chem Pap"},{"key":"3382_CR61","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0168-3659(02)00009-3","volume":"82","author":"AV Kabanov","year":"2002","unstructured":"Kabanov AV, Batrakova EV, Yu V. Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release. 2002;82:189\u2013212.","journal-title":"J Control Release"},{"key":"3382_CR62","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejpb.2016.12.032","volume":"114","author":"S Tima","year":"2017","unstructured":"Tima S, Anuchapreeda S, Ampasavate C, Berkland C, Okonogi S. Stable curcumin-loaded polymeric micellar formulation for enhancing cellular uptake and cytotoxicity to FLT3 overexpressing EoL-1 leukemic cells. Eur J Pharm Biopharm. 2017;114:57\u201368.","journal-title":"Eur J Pharm Biopharm"},{"key":"3382_CR63","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jconrel.2003.11.003","volume":"95","author":"SR Croy","year":"2004","unstructured":"Croy SR, Kwon GS. The effects of Pluronic block copolymers on the aggregation state of nystatin. J Control Release. 2004;95:161\u201371.","journal-title":"J Control Release"},{"key":"3382_CR64","first-page":"1","volume":"17","author":"F Nowroozi","year":"2018","unstructured":"Nowroozi F, Almasi A, Javidi J, Haeri A, Dadashzadeh S. Effect of surfactant type, cholesterol content and various downsizing methods on the particle size of niosomes. Iran J Pharm Res. 2018;17:1.","journal-title":"Iran J Pharm Res"},{"key":"3382_CR65","doi-asserted-by":"crossref","first-page":"346","DOI":"10.4103\/1735-5362.213979","volume":"12","author":"S Shaker","year":"2017","unstructured":"Shaker S, Gardouh AR, Ghorab MM. Factors affecting liposomes particle size prepared by ethanol injection method. Res Pharm Sci. 2017;12:346\u201352.","journal-title":"Res Pharm Sci"},{"key":"3382_CR66","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.3390\/polym11101632","volume":"11","author":"AA \u00d6zt\u00fcrk","year":"2019","unstructured":"\u00d6zt\u00fcrk AA, Yenilmez E, \u00d6zarda MG. Clarithromycin-loaded poly (lactic-co-glycolic acid)(PLGA) nanoparticles for oral administration: effect of polymer molecular weight and surface modification with chitosan on formulation, nanoparticle characterization and antibacterial effects. Polymers (Basel). 2019;11:1632.","journal-title":"Polymers (Basel)"},{"key":"3382_CR67","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejpb.2016.10.017","volume":"109","author":"G B\u00fcy\u00fckk\u00f6ro\u011flu","year":"2016","unstructured":"B\u00fcy\u00fckk\u00f6ro\u011flu G, \u015eenel B, Ba\u015faran E, Yenilmez E, Yazan Y. Preparation and in vitro evaluation of vaginal formulations including siRNA and paclitaxel-loaded SLNs for cervical cancer. Eur J Pharm Biopharm. 2016;109:174\u201383.","journal-title":"Eur J Pharm Biopharm"},{"key":"3382_CR68","first-page":"19670","volume":"8","author":"SB Sun","year":"2015","unstructured":"Sun SB, Liu P, Shao FM, Miao QL. Formulation and evaluation of PLGA nanoparticles loaded capecitabine for prostate cancer. Int J Clin Exp Med. 2015;8:19670\u201381.","journal-title":"Int J Clin Exp Med"},{"key":"3382_CR69","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1016\/j.actbio.2011.07.025","volume":"7","author":"U Seju","year":"2011","unstructured":"Seju U, Kumar A, Sawant KK. Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies. Acta Biomater. 2011;7:4169\u201376. https:\/\/doi.org\/10.1016\/j.actbio.2011.07.025.","journal-title":"Acta Biomater"},{"key":"3382_CR70","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0168-3659(00)00364-3","volume":"71","author":"S Feng","year":"2001","unstructured":"Feng S, Huang G. Effects of emulsifiers on the controlled release of paclitaxel (Taxol\u00ae) from nanospheres of biodegradable polymers. J Control Release. 2001;71:53\u201369.","journal-title":"J Control Release"},{"key":"3382_CR71","doi-asserted-by":"publisher","DOI":"10.1590\/s2175-97902019000318069","author":"AV Fernandes","year":"2020","unstructured":"Fernandes AV, Pydi CR, Verma R, Jose J, Kumar L. Design, preparation and in vitro characterizations of fluconazole loaded nanostructured lipid carriers. Braz J Pharm Sci. 2020. https:\/\/doi.org\/10.1590\/s2175-97902019000318069.","journal-title":"Braz J Pharm Sci"},{"key":"3382_CR72","doi-asserted-by":"crossref","first-page":"21712","DOI":"10.1021\/acsomega.0c02618","volume":"5","author":"N Badawi","year":"2020","unstructured":"Badawi N, El-Say K, Attia D, El-Nabarawi M, Elmazar M, Teaima M. Development of pomegranate extract-loaded solid lipid nanoparticles: quality by design approach to screen the variables affecting the quality attributes and characterization. ACS Omega. 2020;5:21712\u201321.","journal-title":"ACS Omega"},{"key":"3382_CR73","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/15583724.2013.862544","volume":"54","author":"QTH Shubhra","year":"2014","unstructured":"Shubhra QTH, T\u00f3th J, Gyenis J, Feczk\u00f3 T. Poloxamers for surface modification of hydrophobic drug carriers and their effects on drug delivery. Polym Rev. 2014;54:112\u201338.","journal-title":"Polym Rev"},{"key":"3382_CR74","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1208\/s12249-009-9342-y","volume":"10","author":"AO Kamel","year":"2009","unstructured":"Kamel AO, Awad GAS, Geneidi AS, Mortada ND. Preparation of intravenous stealthy acyclovir nanoparticles with increased mean residence time. AAPS PharmSciTech. 2009;10:1427\u201336.","journal-title":"AAPS PharmSciTech"},{"key":"3382_CR75","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.colsurfb.2011.12.004","volume":"92","author":"CK Song","year":"2012","unstructured":"Song CK, Balakrishnan P, Shim CK, Chung SJ, Chong S, Kim DD. A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro\/in vivo evaluation. Colloids Surf B Biointerfaces. 2012;92:299\u2013304. https:\/\/doi.org\/10.1016\/j.colsurfb.2011.12.004.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3382_CR76","first-page":"34","volume":"2","author":"H Soni","year":"2024","unstructured":"Soni H, Kumawat S, Sharma V, Ravindra N. An overview on topical gel drug delivery systems. Int J Health Adv Clin Res. 2024;2:34\u20138.","journal-title":"Int J Health Adv Clin Res"},{"key":"3382_CR77","first-page":"459","volume":"4","author":"SM Soliman","year":"2010","unstructured":"Soliman SM, Malak NSA, El-Gazayerly ON, Rehim AAA. Formulation of microemulsion gel systems for transdermal delivery of celecoxib: In vitro permeation, anti-inflammatory activity and skin irritation tests. Drug Discov Ther. 2010;4:459\u201371.","journal-title":"Drug Discov Ther"},{"key":"3382_CR78","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1208\/s12249-025-03148-x","volume":"26","author":"K Al-Smadi","year":"2025","unstructured":"Al-Smadi K, Ali M, Zhu J, Abdoh A, Phan K, Mohammed Y. Advances in characterization of transdermal and topical products using texture analyzer systems. AAPS PharmSciTech. 2025;26:157.","journal-title":"AAPS PharmSciTech"},{"key":"3382_CR79","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.3390\/ma4101861","volume":"4","author":"SC Joshi","year":"2011","unstructured":"Joshi SC. Sol-gel behavior of hydroxypropyl methylcellulose (HPMC) in ionic media including drug release. Materials. 2011;4:1861\u2013905.","journal-title":"Materials"},{"key":"3382_CR80","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/drd_10_4_251","volume":"10","author":"J Varshosaz","year":"2003","unstructured":"Varshosaz J, Pardakhty A, Hajhashemi V, Najafabadi AR. Development and physical characterization of sorbitan monoester niosomes for insulin oral delivery. Drug Deliv. 2003;10:251\u201362.","journal-title":"Drug Deliv"},{"key":"3382_CR81","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.colsurfb.2018.05.028","volume":"169","author":"S Fatima","year":"2018","unstructured":"Fatima S, Iqbal Z, Panda AK, Samim M, Talegaonkar S, Ahmad FJ. Polymeric nanoparticles as a platform for permeability enhancement of class III drug amikacin. Colloids Surf, B. 2018;169:206\u201313.","journal-title":"Colloids Surf, B"},{"key":"3382_CR82","first-page":"301","volume":"64","author":"D Pandita","year":"2009","unstructured":"Pandita D, Ahuja A, Velpandian T, Lather V, Dutta T, Khar RK. Characterization and in vitro assessment of paclitaxel loaded lipid nanoparticles formulated using modified solvent injection technique. Die Pharm Int J Pharm Sci. 2009;64:301\u201310.","journal-title":"Die Pharm Int J Pharm Sci"},{"key":"3382_CR83","doi-asserted-by":"crossref","first-page":"223","DOI":"10.5604\/01.3001.0012.8351","volume":"8","author":"M Niczyporuk","year":"2018","unstructured":"Niczyporuk M. Rat skin as an experimental model in medicine. Prog Health Sci. 2018;8:223\u20138.","journal-title":"Prog Health Sci"},{"key":"3382_CR84","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/0883911520913906","volume":"35","author":"F Pervaiz","year":"2020","unstructured":"Pervaiz F, Saleem M, Ashames A, Rehmani S, Qaiser R, Noreen S, et al. Development and ex-vivo skin permeation studies of finasteride\u2013poly (lactic acid-co-glycolic acid) and minoxidil\u2013chitosan nanoparticulate systems. J Bioact Compat Polym. 2020;35:77\u201391.","journal-title":"J Bioact Compat Polym"},{"key":"3382_CR85","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ijpharm.2012.07.048","volume":"437","author":"C Van Hemelrijck","year":"2012","unstructured":"Van Hemelrijck C, M\u00fcller-Goymann CC. Rheological characterization and permeation behavior of poloxamer 407-based systems containing 5-aminolevulinic acid for potential application in photodynamic therapy. Int J Pharm. 2012;437:120\u20139. https:\/\/doi.org\/10.1016\/j.ijpharm.2012.07.048.","journal-title":"Int J Pharm"},{"key":"3382_CR86","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/0975-7406.92724","volume":"4","author":"I Som","year":"2012","unstructured":"Som I, Bhatia K, Yasir M. Status of surfactants as penetration enhancers in transdermal drug delivery. J Pharm Bioallied Sci. 2012;4:2\u20139.","journal-title":"J Pharm Bioallied Sci"},{"key":"3382_CR87","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3390\/ijms16011232","volume":"16","author":"Y-C Oh","year":"2015","unstructured":"Oh Y-C, Jeong YH, Cho W-K, Ha J-H, Gu MJ, Ma JY. Anti-inflammatory and analgesic effects of pyeongwisan on LPS-stimulated murine macrophages and mouse models of acetic acid-induced writhing response and xylene-induced ear edema. Int J Mol Sci. 2015;16:1232\u201351.","journal-title":"Int J Mol Sci"},{"key":"3382_CR88","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","volume":"4","author":"S Akira","year":"2004","unstructured":"Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4:499\u2013511.","journal-title":"Nat Rev Immunol"},{"key":"3382_CR89","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","volume":"11","author":"T Kawai","year":"2010","unstructured":"Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010;11:373\u201384.","journal-title":"Nat Immunol"},{"key":"3382_CR90","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5021\/ad.2008.20.2.56","volume":"20","author":"HR Cho","year":"2008","unstructured":"Cho HR, Cho Y, Kim J, Seo DB, Kim SH, Lee SJ, et al. The effect of gromwell (Lithospermum erythrorhizon) extract on the stratum corneum hydration and ceramides content in atopic dermatitis patients. Ann Dermatol. 2008;20:56\u201366.","journal-title":"Ann Dermatol"},{"key":"3382_CR91","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/BF02980087","volume":"27","author":"H Lim","year":"2004","unstructured":"Lim H, Park H, Kim HP. Inhibition of contact dermatitis in animal models and suppression of proinflammatory gene expression by topically applied flavonoid, wogonin. Arch Pharm Res. 2004;27:442\u20138.","journal-title":"Arch Pharm Res"},{"key":"3382_CR92","first-page":"52","volume":"4","author":"F Zahra","year":"2018","unstructured":"Zahra F, Rahman AM. Medicinal us Bangladesh. Sci Technol. 2018;4:52\u201370.","journal-title":"Sci Technol"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03382-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03382-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03382-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:52:07Z","timestamp":1780390327000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03382-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":92,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["3382"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03382-x","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Research Ethics Committee for Experimental and Clinical Studies at the Faculty of Pharmacy, Cairo University, Cairo, Egypt (Protocol Serial Number: PI (3322)). All procedures were conducted in accordance with national and institutional guidelines for the care and use of laboratory animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"155"}}